GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
184 hedge funds and large institutions have $2.02B invested in Global Blood Therapeutics, Inc. in 2018 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 73 increasing their positions, 58 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
32% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 37
Holders
184
Holding in Top 10
6
Calls
$75M
Puts
$25.2M
Top Buyers
| 1 | +$51.6M | |
| 2 | +$50.1M | |
| 3 | +$20.8M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$17.1M |
| 5 |
PA
Perceptive Advisors
New York
|
+$12.2M |
Top Sellers
| 1 | -$34.8M | |
| 2 | -$33.7M | |
| 3 | -$19.7M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$15.7M |
| 5 |
KCM
Kingdon Capital Management
New York
|
-$10.2M |